Details
Title
Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics
Author
Carter, Bing Z. 1
; Mak, Po Yee 1 ; Tao, Wenjing 1 ; Ayoub, Edward 1 ; Ostermann, Lauren B. 1
; Huang, Xuelin 2 ; Loghavi, Sanam 3
; Boettcher, Steffen 4
; Nishida, Yuki 1 ; Ruvolo, Vivian 1 ; Hughes, Paul E. 5 ; Morrow, Phuong K. 6 ; Haferlach, Torsten 7
; Kornblau, Steven 1
; Muftuoglu, Muharrem 1 ; Andreeff, Michael 1
1 The University of Texas MD Anderson Cancer Center, Section of Molecular Hematology and Therapy, Department of Leukemia, Houston, USA (GRID:grid.240145.6) (ISNI:0000 0001 2291 4776)
2 The University of Texas MD Anderson Cancer Center, Department of Biostatistics, Houston, USA (GRID:grid.240145.6) (ISNI:0000 0001 2291 4776)
3 The University of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, USA (GRID:grid.240145.6) (ISNI:0000 0001 2291 4776)
4 University Hospital Zurich and University of Zurich, Department of Medical Oncology and Hematology, Zurich, Switzerland (GRID:grid.412004.3) (ISNI:0000 0004 0478 9977)
5 Oncology Research, Amgen Inc, Thousand Oaks, USA (GRID:grid.417886.4) (ISNI:0000 0001 0657 5612)
6 Amgen Inc, Thousand Oaks, USA (GRID:grid.417886.4) (ISNI:0000 0001 0657 5612)
7 MLL Munich Leukemia Laboratory, Munich, Germany (GRID:grid.420057.4) (ISNI:0000 0004 7553 8497)
; Mak, Po Yee 1 ; Tao, Wenjing 1 ; Ayoub, Edward 1 ; Ostermann, Lauren B. 1
; Huang, Xuelin 2 ; Loghavi, Sanam 3
; Boettcher, Steffen 4
; Nishida, Yuki 1 ; Ruvolo, Vivian 1 ; Hughes, Paul E. 5 ; Morrow, Phuong K. 6 ; Haferlach, Torsten 7
; Kornblau, Steven 1
; Muftuoglu, Muharrem 1 ; Andreeff, Michael 1
1 The University of Texas MD Anderson Cancer Center, Section of Molecular Hematology and Therapy, Department of Leukemia, Houston, USA (GRID:grid.240145.6) (ISNI:0000 0001 2291 4776)
2 The University of Texas MD Anderson Cancer Center, Department of Biostatistics, Houston, USA (GRID:grid.240145.6) (ISNI:0000 0001 2291 4776)
3 The University of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, USA (GRID:grid.240145.6) (ISNI:0000 0001 2291 4776)
4 University Hospital Zurich and University of Zurich, Department of Medical Oncology and Hematology, Zurich, Switzerland (GRID:grid.412004.3) (ISNI:0000 0004 0478 9977)
5 Oncology Research, Amgen Inc, Thousand Oaks, USA (GRID:grid.417886.4) (ISNI:0000 0001 0657 5612)
6 Amgen Inc, Thousand Oaks, USA (GRID:grid.417886.4) (ISNI:0000 0001 0657 5612)
7 MLL Munich Leukemia Laboratory, Munich, Germany (GRID:grid.420057.4) (ISNI:0000 0004 7553 8497)
Pages
80
Publication year
2023
Publication date
Dec 2023
e-ISSN
20445385
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2814206728
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.